

LONDON (Alliance News) - Moody's Investors Service late Wednesday expressed uncertainty regarding biotechnology company Shire PLC's credit profile fol...


LONDON (Alliance News) - Stocks in London are set to open marginally higher on Thursday, supported by some gains in the US overnight, with focus for t...


ZURICH, April 26 (Reuters) - Roche raised its 2018 sales outlook on Thursday after getting a lift in the first three months of the year from newer dru...


BRUSSELS/FRANKFURT/PARIS (Alliance News) - The European markets ended Wednesday's session firmly in negative territory. Investor sentiment took a hit ...


Editor: Steve Orlofsky +1 646 223 6200 Global Picture Desk: +65 6870 3775 Global Graphics Desk: + 65 6870 3595 (All times GMT / ET) Receive this sched...


Editor: Louise Heavens, +44 207 542 1897 Global Picture Desk: +65 6870 3775 Global Graphics Desk: + 65 6870 3595 (All times GMT / ET) Receive this sch...


LONDON, April 25 (Reuters) - GlaxoSmithKline's chief executive said on Wednesday she had no interest in acquiring Shire, the London-listed rare diseas...


* CEO Weber continuing predecessor's international push * Japan already accounts for only 30 percent of Takeda's drug sales * Takeda is trying to rebu...